Last reviewed · How we verify
NCT05169892
Aquablation in Benign Prostatic Hyperplasia in Canada
trial testing Aquablation in Urologic Diseases in 25 participants. Currently enrolling.
31 December 2023
Quick facts
| Lead sponsor | Can-Am HIFU Inc. |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 25 |
| Start date | 9 October 2019 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Aquablation
Conditions studied
- Urologic Diseases — all drugs for Urologic Diseases →
Sponsor
Can-Am HIFU Inc.
Who can join
18 and older, male only, with Urologic Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To document the clinical outcome of Aquablation therapy for BPH patient in Canadian cohort.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05169892
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Aquablation
Trials testing the same drug.
- NCT03938194 — Waterjet Prostate Ablation · NA · terminated
- NCT02974751 — Global Post-Market Registry Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue · unknown
- NCT03123250 — Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II · NA · completed
Other recruiting trials for Urologic Diseases
Currently open trials in the same condition.
- NCT07378358 — Evaluation of AI Large Models for Diagnosis and Treatment in Real-World Cases: Multicenter Retrospective Study · recruiting
- NCT07338292 — VIrtual Reality Induced Pain and anxiEty Relief in Outpatient UROlogical Procedures · NA · recruiting
- NCT06676527 — Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma · recruiting
- NCT06531473 — Laser Outcomes Associated With (Holmium Laser Enucleation of the Prostate) HoLEP Procedures · NA · recruiting
- NCT07395037 — A Study of Ward Admissions for Haematuria · recruiting
Other Can-Am HIFU Inc. trials
Trials by the same sponsor.
- NCT05201131 — Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH). · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05169892 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Can-Am HIFU Inc.
- Last refreshed: 27 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05169892.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing